Curis | CRIS - الربح قبل الضريبة





الربح قبل الضريبة تغيير تاريخ
Alaunos Therapeutics USD -7.84M 633K 2023-12
Amgen USD 2.08B 570M 2026-03
AstraZeneca USD 4.81B 894M 2026-06
Bayer EUR 321M 2.67B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
CSL USD 2.61B 1.21B 2025-12
Curis USD -24.2M 43.56M 2026-03
Eli Lilly USD 8.85B 583.8M 2026-03
Exelixis USD 262.68M 5.01M 2026-06
Gilead Sciences USD -7.53B 10.11B 2026-06
GlaxoSmithKline GBP 2.68B 532M 2026-06
Incyte USD 751.51M 407.91M 2026-06
Merck USD -3.53B 6.95B 2026-03
Novartis USD 4.27B 430M 2026-06
Pfizer USD -653M 5.84B 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR 837M 1.17B 2026-06
Takeda JPY 162.72B 215.2B 2026-06
TG Therapeutics USD 10.23M 10.13M 2026-06
Verastem USD -36.59M 3.68M 2026-03